Allergy Testing - Book an appointment online Allergy Testing Survey
Book an appointment online Request an allergy test Register as a new patient

London Allergy & Immunology Centre

Peanut Allergy:
Emergency Action Plan (UK)

Evidence-based guidance aligned with the EAACI 2025 IgE-mediated food allergy management guidelines and BSACI Palforzia prescribing guidance (2024).

⚠ IF IN DOUBT — USE YOUR ADRENALINE AUTO-INJECTOR AND CALL 999

About Peanut Allergy in the UK

Peanut allergy is one of the most common and potentially serious food allergies in the United Kingdom. It affects approximately 1–2% of children and adults, and unlike many childhood food allergies, it persists into adulthood in the majority of cases. Peanut is the leading cause of food-induced fatal and near-fatal anaphylaxis in the UK.

Peanut allergy is an IgE-mediated hypersensitivity reaction triggered by proteins within the peanut (Arachis hypogaea). The principal allergenic proteins are designated Ara h 1 through Ara h 13. In the UK, Ara h 2 (a 2S albumin seed storage protein) is the dominant allergen and the most clinically important marker of true peanut allergy, conferring the highest risk of severe systemic reactions. Sensitisation to Ara h 8 (a birch pollen cross-reactive protein) is associated with milder oral allergy syndrome rather than anaphylaxis.

Key Facts

  • Affects approximately 1–2% of people in the UK
  • Persists into adulthood in around 80% of cases
  • Leading cause of food-induced fatal anaphylaxis
  • Reactions can occur from trace exposures as small as 1.6 mg of peanut protein

High-Risk Groups

  • Individuals with co-existing asthma (especially poorly controlled)
  • Adolescents and young adults (highest fatality rate)
  • Those with high Ara h 2-specific IgE levels
  • Patients with previous severe anaphylactic reactions

Important Note

Peanuts are not tree nuts — they are legumes. However, many people with peanut allergy are also advised to avoid tree nuts due to the risk of cross-contamination in processing and manufacturing. Your allergist will advise on an individual basis.

Recognising an Allergic Reaction to Peanut

Symptoms typically develop within minutes to two hours of ingestion (or, less commonly, contact or inhalation of peanut proteins). The reaction may affect one or more body systems simultaneously. The speed of onset and involvement of multiple systems are key indicators of severity.

▲ Mouth & Throat

  • Tingling or itching of lips, mouth, or tongue
  • Swelling of the lips, tongue, or throat (angioedema)
  • Hoarse voice or change in voice quality
  • Difficulty swallowing or choking sensation

▲ Breathing

  • Shortness of breath or rapid breathing
  • Wheezing or audible wheeze
  • Chest tightness or chest pain
  • Persistent or worsening cough

▲ Circulation

  • Feeling faint, dizzy, or light-headed
  • Rapid, weak, or irregular pulse
  • Pale, grey, or clammy skin
  • Collapse or loss of consciousness

▲ Skin

  • Widespread urticaria (hives)
  • Flushing or generalised redness
  • Intense itching of skin
  • Localised or spreading swelling

▲ Gut & Other

  • Nausea, vomiting or stomach cramps
  • Diarrhoea
  • Sense of impending doom
  • Confusion or agitation (especially in children)

Anaphylaxis warning: Do not wait for all symptoms to develop. Involvement of the airway, breathing, or circulation — particularly in combination with recent peanut ingestion — constitutes anaphylaxis. Act immediately: use your adrenaline auto-injector and call 999. Antihistamines alone will not treat anaphylaxis.

Biphasic anaphylaxis: A second wave of symptoms can occur 1–72 hours after the initial reaction in up to 20% of cases, even if the first reaction has subsided. This is why all patients who experience anaphylaxis must be observed in hospital for a minimum of 4–6 hours, or longer if the reaction was severe.

Emergency Action Steps — What to Do Immediately

1

Stop eating immediately

If peanut ingestion is suspected, stop eating at once. Do not attempt to induce vomiting. Spit out any remaining food if possible. Call for help from anyone nearby.

2

Alert someone nearby

Tell a colleague, family member, or bystander that you have eaten peanut and may be having an allergic reaction. Tell them where your adrenaline auto-injector is kept. Do not remain alone.

3

Choose the correct position

Lie flat with legs raised if you feel faint or dizzy. Sit upright if you have breathing difficulties. Recovery position (on your side) if unconscious or vomiting. Never stand up suddenly during a severe reaction — this can cause sudden cardiac arrest due to a severe drop in blood pressure.

4

USE YOUR ADRENALINE AUTO-INJECTOR if ANY of these are present:

  • Throat tightness, hoarse voice, stridor, or difficulty swallowing
  • Shortness of breath, wheeze, or persistent cough
  • Chest tightness or pain
  • Feeling faint, dizzy, or about to collapse
  • Rapid spread of urticaria with any airway or circulatory feature
  • Rapidly worsening or severe multi-system reaction

Inject into the outer mid-thigh. Can be given through clothing. Hold for 10 seconds. Note the time of injection.

5

Call 999 immediately after using adrenaline

Say: “I am having a severe allergic reaction (anaphylaxis) to peanut. I have used my adrenaline auto-injector. I need a paramedic ambulance.” State your exact location. Even if symptoms improve, you must go to hospital. Do not drive yourself.

6

Second dose of adrenaline if no improvement after 5 minutes

If symptoms do not improve or worsen within 5 minutes, use your second adrenaline auto-injector in the opposite thigh. Per RCUK 2021 guidelines, repeat intramuscular adrenaline at 5 minutes is appropriate where the clinical picture does not resolve. Always carry two auto-injectors — this is an MHRA requirement for all patients prescribed these devices.

7

For mild reactions only — antihistamine

If the reaction is mild and limited to skin symptoms only (e.g. itching, limited urticaria) without any airway, breathing, or circulatory involvement, a non-sedating antihistamine (cetirizine 10 mg, loratadine 10 mg, or fexofenadine 120 mg) may be appropriate. Antihistamines must never be used instead of adrenaline where anaphylaxis features are present. They are slow-acting and will not prevent anaphylaxis from progressing. Monitor closely for any deterioration and follow your personalised written plan from your allergy specialist.

How to Use Your Adrenaline Auto-Injector

Technique varies between devices — EpiPen, Jext, and Emerade each operate slightly differently. Always practise regularly with a trainer device and follow the specific instructions for your prescribed device. The general principles are:

1

Remove device from carrier tube. Pull off the safety cap (blue cap on EpiPen; yellow on Jext).

2

Grip firmly in dominant hand. Do not place thumb over the tip.

3

Press needle end firmly against the outer mid-thigh. Can be given through clothing.

4

Push until a click is heard or felt. Hold firmly for 10 seconds.

5

Remove and massage gently. Hand the used device to paramedics. Do not re-cap the needle.

Correct doses (EAACI / BSACI guidance):

  • Children 7.5 kg – 25 kg: 0.15 mg adrenaline (e.g. EpiPen Jr, Jext 150 micrograms)
  • Children over 25–30 kg and adults: 0.3 mg adrenaline (e.g. EpiPen, Jext 300 micrograms)
  • Always carry two devices at all times
  • Check expiry dates monthly and replace before expiry — expired devices deliver reduced adrenaline doses

Mild vs Severe Reactions: How to Tell the Difference

Peanut reactions can progress very quickly from mild to life-threatening. When in doubt, always treat as severe. The table below provides a general guide, but your personalised written plan from your allergy specialist takes precedence.

Feature Mild Reaction Severe Reaction / Anaphylaxis
Skin Localised urticaria, mild itching, mild lip tingling Widespread urticaria, rapidly spreading swelling, angioedema of face/tongue
Airway Mild oral tingling only Throat tightness, hoarse voice, stridor, difficulty swallowing
Breathing None affected Wheeze, shortness of breath, chest tightness
Circulation None affected Faintness, dizziness, pale/grey skin, collapse
Treatment Antihistamine. Monitor closely. Follow your personalised plan. Adrenaline auto-injector IMMEDIATELY. Call 999.

Important: The absence of skin symptoms does not rule out anaphylaxis. Cardiovascular collapse can occur without any urticaria or rash. If you are unsure which category applies, treat as a severe reaction.

Diagnosis and Allergy Testing for Peanut Allergy

Accurate diagnosis of peanut allergy is essential, since a positive peanut IgE blood test alone does not confirm clinical allergy. In the UK, 11.8% of school-aged children have detectable peanut-specific IgE, yet only 2.6% are truly allergic when formally challenged. Misdiagnosis can lead to unnecessary dietary restriction and anxiety, or dangerous under-diagnosis. Our specialist consultants use a structured diagnostic approach:

Clinical History

Detailed account of all previous reactions — nature, timing, severity, and circumstances. Assessment of co-existing conditions (asthma, eczema, hay fever) which influence risk stratification.

Skin Prick Testing

Standardised peanut extract applied to the forearm. A rapid, safe, and sensitive first-line test. Results available within 15–20 minutes. Performed by a trained specialist nurse or allergist.

Specific IgE Blood Tests

Total peanut-specific IgE (f13). Component testing including Ara h 2 — the most accurate single diagnostic marker for true peanut allergy in the UK. High Ara h 2-sIgE correlates with severe reactions.

Molecular Allergy Testing

ALEX (300 allergen components) or ISAC molecular testing profiles the full range of peanut proteins including Ara h 1, 2, 3, 6, 8, and 9. Distinguishes true peanut allergy from birch pollen cross-reactivity (Ara h 8), preventing over-diagnosis and unnecessary avoidance.

Supervised Food Challenge

A double-blind placebo-controlled food challenge (DBPCFC) remains the gold standard for confirming or excluding peanut allergy. Conducted in our fully equipped clinic under close medical supervision with resuscitation facilities. May be used to confirm diagnosis or assess resolution of allergy.

Baseline Tryptase

Serum tryptase measurement helps identify underlying mast cell disorders (e.g. mastocytosis), which significantly increase anaphylaxis risk and may influence treatment decisions, including prescription of omalizumab alongside oral immunotherapy.

Peanut Oral Immunotherapy (OIT) — The Only Disease-Modifying Treatment

Peanut oral immunotherapy (POIT) is now recommended by the 2025 EAACI guidelines for children and adolescents with confirmed peanut allergy. It is the only treatment that can modify the underlying allergic disease, reducing the risk of severe reactions from accidental exposures by substantially raising the threshold of reactivity.

Palforzia® — The Licensed Peanut OIT Product in the UK

Palforzia® (defatted peanut powder) is the only licensed medicinal product for peanut oral immunotherapy in the UK and Europe, approved for patients aged 4–17 years. The BSACI published updated prescribing guidance for Palforzia® in 2024 to support consistent and safe delivery by allergy specialists.

Treatment involves three phases: an initial escalation (conducted in clinic under supervision), an up-dosing phase (weekly dose increases at clinic visits over several months), and a daily maintenance phase (ongoing daily ingestion of peanut protein at home). The goal is desensitisation — protecting against accidental exposures — and, in some patients, the development of sustained unresponsiveness.

Who is Eligible?

  • Children and adolescents aged 4–17 with confirmed IgE-mediated peanut allergy
  • Diagnosis confirmed by food challenge, skin testing, and/or Ara h 2 testing
  • Well-controlled or no asthma (active asthma is a contraindication)

What to Expect

  • Multiple supervised clinic visits during escalation and up-dosing phases
  • Daily home doses between visits
  • Common side effects: mild oral or GI symptoms during dose increases
  • Adrenaline auto-injector must always be carried throughout treatment

Omalizumab (Xolair) Add-On

  • EAACI 2025 guidelines suggest omalizumab for IgE-mediated food allergy in children from age 1 and adults as an immunomodulatory option
  • Combination with OIT may improve safety and speed of desensitisation in highly sensitive patients
  • Discussed individually at specialist consultation

Adults and OIT: Current EAACI guidance recommends POIT for children and adolescents up to 17 years. For adults with peanut allergy, management currently centres on avoidance, emergency medication, and — where appropriate — omalizumab monotherapy. Research into adult OIT protocols is ongoing. Our consultants can advise on the most up-to-date treatment options at your consultation.

Peanut Avoidance and Food Labelling in the UK

Under UK food labelling law (retained from EU Regulation 1169/2011), peanut is one of 14 major allergens that must be clearly declared on pre-packed food labels, typically in bold. However, risk from unlabelled or loosely packed foods and cross-contamination remains significant.

Reading Labels

  • Always read the full ingredient list, not just allergy summaries
  • Look out for alternative names: groundnut, monkey nut, mixed nuts, arachis oil, beer nuts
  • “May contain peanut” or “made in a factory that handles peanuts” warnings are voluntary and indicate genuine cross-contamination risk
  • Re-read labels every time — recipes change without notice

Eating Out Safely

  • Always inform waiting staff and kitchen of your allergy before ordering
  • Ask to speak to the manager or chef for high-risk dishes
  • Be particularly cautious with Asian, Middle Eastern, and African cuisines where peanut is used extensively
  • Carry written allergy cards — available free from Allergy UK

Hidden Sources of Peanut

  • Satay sauces, noodle dishes, stir-fries
  • Baked goods, cereal bars, and flapjacks
  • Some cooking oils, salad dressings, and marinades
  • Some cosmetic products (e.g. certain baby lotions) — inhalation/skin contact risk

Always Carry

  • Two in-date adrenaline auto-injectors
  • Non-sedating antihistamine tablets
  • Your personalised written emergency action plan
  • MedicAlert or similar medical ID bracelet or card

Managing Peanut Allergy at School, University, and Work

For Schools (Children)

  • Provide the school with a copy of the child’s written emergency action plan, signed by your allergy specialist
  • Ensure the school holds two spare adrenaline auto-injectors in an accessible, clearly labelled location
  • Ensure relevant staff (teachers, lunchtime supervisors, sports coaches) are trained in recognition and use of the auto-injector
  • Update the plan and device supply at the start of each academic year
  • Schools in England may hold a spare adrenaline auto-injector for emergency use under the Human Medicines Regulations 2017 amendment

For Adults (University / Workplace)

  • Inform your employer or university disability/health team of your allergy and emergency plan
  • Keep a spare auto-injector in a secure but accessible location at your desk or workplace first-aid point
  • Consider a MedicAlert bracelet or wallet card — essential if you are alone or unconscious
  • Register with Allergy UK’s free allergy alert service for dining and travel
  • Review your plan with your allergy specialist at least annually or after any reaction

Arrange a Specialist Peanut Allergy Assessment in London

If you or your child has experienced a reaction to peanut, or if you have a positive test result without a clear diagnosis, specialist assessment is essential. Our consultants at the London Allergy and Immunology Centre — Harley Street, City of London, and East London — offer a comprehensive service:

Full Peanut Allergy Workup

Skin prick testing, specific IgE, Ara h 2 component testing, ALEX and ISAC molecular panels, baseline tryptase

Supervised Food Challenges

Gold-standard diagnostic and threshold-assessment food challenges with full resuscitation facilities on site

Peanut OIT / Palforzia®

Licensed peanut oral immunotherapy for eligible children and adolescents, following BSACI 2024 prescribing guidance

Emergency Plans & Training

Personalised written emergency action plans, adrenaline auto-injector training, school letters, and dietary advice

Frequently Asked Questions

My child tested positive for peanut IgE but has never reacted. Do they have peanut allergy?

Not necessarily. Sensitisation (a positive IgE test) does not equal clinical allergy. In the UK, many children test positive but are not genuinely allergic. Component testing, particularly for Ara h 2, and a supervised food challenge are essential to establish whether your child has true peanut allergy and to define their threshold of reactivity. An allergy specialist assessment is strongly recommended before placing any child on a peanut-free diet.

Is Palforzia® available privately in London? Who can prescribe it?

Yes. Palforzia® is available privately at specialist allergy clinics with appropriate facilities and trained staff. The BSACI 2024 guidance sets out the clinical and infrastructure requirements for prescribers. At the London Allergy and Immunology Centre, our consultants can assess eligibility, obtain informed consent, and administer the full treatment programme. A detailed pre-treatment workup including food challenge and molecular testing is required before starting.

Can adults develop peanut allergy for the first time?

Yes, though it is less common than childhood-onset peanut allergy. Adult-onset peanut allergy does occur and can present de novo without any prior childhood reactions. Any adult experiencing unexplained urticaria, angioedema, or anaphylaxis following peanut ingestion should be referred to an allergy specialist for full assessment.

Do I need to avoid all tree nuts if I have peanut allergy?

Peanuts are botanically a legume, not a tree nut. However, co-sensitisation to tree nuts is common, and cross-contamination during food manufacturing is a real risk. Whether you need to avoid tree nuts depends on the results of your individual allergy testing. Many people with peanut allergy can safely eat some or all tree nuts. Your allergy specialist will advise based on your test results and clinical history.

My child is due to start peanut OIT. Should they still carry an adrenaline auto-injector?

Yes, absolutely. Throughout the entire course of peanut OIT — including during the maintenance phase — patients must continue to carry two adrenaline auto-injectors at all times. OIT raises the threshold of reactivity but does not eliminate the risk of anaphylaxis. Reactions can still occur, particularly during dose escalation, with exercise after dosing, or during intercurrent illness. Your allergy specialist will review auto-injector requirements at each clinic visit.

Important Notice

This page provides general educational information and is not a substitute for individual medical advice. Emergency action plans must be personalised by your allergy specialist for your specific circumstances. Always follow your own written plan from your doctor. In an emergency, call 999 immediately.

References and Further Reading

  1. Santos AF, Riggioni C, Agache I, et al. EAACI Guidelines on the Management of IgE-mediated Food Allergy. Allergy. 2025;80(1):1–28. doi:10.1111/all.16345
  2. BSACI. Guidance for Prescribing Palforzia® Peanut Oral Immunotherapy. British Society for Allergy and Clinical Immunology, 2024.
  3. Chowdhury EA, Jadeja OC. The safety and efficacy of oral immunotherapy compared to epicutaneous immunotherapy in peanut allergen desensitisation. Front Allergy. 2025;6:1613237. doi:10.3389/falgy.2025.1613237
  4. Hemmings O, Du Toit G, Radulovic S, Lack G, Santos AF. Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6. J Allergy Clin Immunol. 2020;146(3):621–631.
  5. Resuscitation Council UK. Emergency Treatment of Anaphylaxis: Guidelines for Healthcare Providers. May 2021 (current edition). Available at: resus.org.uk
  6. National Institute for Health and Care Excellence (NICE). Anaphylaxis: Assessment and Referral after Emergency Treatment. CG134. 2011 (reviewed 2020).
  7. Medicines and Healthcare products Regulatory Agency (MHRA). Drug Safety Update: Adrenaline auto-injectors — updated recommendations. 2017.
  8. Allergy UK. Peanut Allergy Factsheet. allergyuk.org
  9. Anaphylaxis UK. Peanut Allergy — Patient and Family Guidance. anaphylaxis.org.uk
  10. NHS. Food Allergy Overview. nhs.uk/conditions/food-allergy

Medically reviewed: June 2026 | London Allergy and Immunology Centre | privateallergy.uk

LAIC Main Menu